Traver Hart,Amy Hin Yan Tong,Katie Chan,Jolanda Van Leeuwen,Ashwin Seetharaman,Michael Aregger,Megha Chandrashekhar,Nicole Hustedt,Sahil Seth,Avery Noonan,Andrea Habsid,Olga Sizova,Lyudmila Nedyalkova,Ryan Climie,Leanne Tworzyanski,Keith Lawson,Maria Augusta Sartori,Sabriyeh Alibeh,David Tieu,Sanna Masud,Patricia Mero,Alexander Weiss,Kevin R Brown,Matej Usaj,Maximilian Billmann,Mahfuzur Rahman,Michael Constanzo,Chad L Myers,Brenda J Andrews,Charles Boone,Daniel Durocher,Jason Moffat,Michael Costanzo

Abstract:Abstract The adaptation of CRISPR/SpCas9 technology to mammalian cell lines is transforming the study of human functional genomics. Pooled libraries of CRISPR guide RNAs (gRNAs) targeting human protein-coding genes and encoded in viral vectors have been used to systematically create gene knockouts in a variety of human cancer and immortalized cell lines, in an effort to identify whether these knockouts cause cellular fitness defects. Previous work has shown that CRISPR screens are more sensitive and specific than pooled-library shRNA screens in similar assays, but currently there exists significant variability across CRISPR library designs and experimental protocols. In this study, we reanalyze 17 genome-scale knockout screens in human cell lines from three research groups, using three different genome-scale gRNA libraries. Using the Bayesian Analysis of Gene Essentiality algorithm to identify essential genes, we refine and expand our previously defined set of human core essential genes from 360 to 684 genes. We use this expanded set of reference core essential genes, CEG2, plus empirical data from six CRISPR knockout screens to guide the design of a sequence-optimized gRNA library, the Toronto KnockOut version 3.0 (TKOv3) library. We then demonstrate the high effectiveness of the library relative to reference sets of essential and nonessential genes, as well as other screens using similar approaches. The optimized TKOv3 library, combined with the CEG2 reference set, provide an efficient, highly optimized platform for performing and assessing gene knockout screens in human cell lines.

Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening

Protocol: Genome-scale CRISPR-Cas9 Knockout and Transcriptional Activation Screening

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation

Genome-Wide CRISPR/Cas9 Screening for High-Throughput Functional Genomics in Human Cells

Protocol to identify receptors of secreted proteins through CRISPR-Cas9 whole-genome screening technology

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

High-Throughput Screens in Mammalian Cells Using the Crispr-Cas9 System

Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells

Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens

CRISPR/Cas9-Mediated Gene Knockout in Cells and Tissues Using Lentivirus.

Arrayed CRISPR libraries for the genome-wide activation, deletion and silencing of human protein-coding genes

Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library

CRISPR gene and transcriptome engineering (CRISPRgate) improves loss-of-function genetic screening approaches

A novel sgRNA selection system for CRISPR-Cas9 in mammalian cells

CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering

Scalable single-cell pooled CRISPR screens with conventional knockout vector libraries

Arrayed CRISPR/Cas9 Screening for the Functional Validation of Cancer Genetic Dependencies

Compact CRISPR genetic screens enabled by improved guide RNA library cloning

Enhanced in vivo gene knockout with undetectable off-targets using multiplexed Cas12a sgRNAs

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

[High-throughput functional screening using CRISPR/Cas9 system].